Jointown Pharmaceutical Group Co Ltd
Jointown Pharmaceutical Group's GHG Emissions Data Preview
In 2024, Jointown Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Jointown Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature.  | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0000000 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 |
Verified Sources Behind Jointown Pharmaceutical Group’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Jointown Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.
Insights into Jointown Pharmaceutical Group's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Jointown Pharmaceutical Group amounted to 47,929.41 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Jointown Pharmaceutical Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Jointown Pharmaceutical Group's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Jointown Pharmaceutical Group were 36,924.21 metric tons of CO₂ equivalent (tCO₂e).a
What are Jointown Pharmaceutical Group's Scope 2 emissions?
In 2024, Jointown Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 11,005.2 tCO₂e without specifying the calculation method.a
What methodology does Jointown Pharmaceutical Group use for Scope 2 reporting?
In 2024, Jointown Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology.a
Jointown Pharmaceutical Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Jointown Pharmaceutical Group’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Jointown Pharmaceutical Group reported Scope 1 greenhouse gas (GHG) emissions of 36,924.21 tCO₂e and total revenues of USD 20,801 millions. This translates into an emissions intensity of 1.78 tCO₂e per millions USD.a
Jointown Pharmaceutical Group's Scope 1 Emissions Intensity Compared to Peers
How does Jointown Pharmaceutical Group's GHG emissions intensity compare to its peers?
In 2024, Jointown Pharmaceutical Group reported a Scope 1 emissions intensity of 1.78 tCO₂e per millions USD. Compared to the peer group median of 11.38, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
Where does Jointown Pharmaceutical Group rank on GHG emissions intensity within its industry?
In 2024, Jointown Pharmaceutical Group ranked 9 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Jointown Pharmaceutical Group is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a